MoneyWorks4Me

Auro Laboratories informs about secretarial compliance report

30 May 2022 Evaluate

In terms of Regulation 24A of SEBI (LODR) Regulations, 2015 read with Clause 3(b)/(iii) of the SEBI Circular no.CIR/CFD/CMD1/27/2019 dated February 8, 2019, Auro Laboratories has submitted the Annual Secretarial Compliance Report of the Company for the year ended March 31, 2022, issued by GMJ & Associates, Practicing Company Secretaries, Mumbai.

The above information is a part of company’s filings submitted to BSE.

Auro Laboratories Share Price

236.25 -2.55 (-1.07%)
17-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1882.50
Dr. Reddys Labs. 1192.00
Cipla 1430.00
Lupin 2259.20
Zydus Lifesciences 1132.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: